Walleye Trading LLC Bicycle Therapeutics PLC Transaction History
Walleye Trading LLC
- $52.6 Billion
- Q2 2025
A detailed history of Walleye Trading LLC transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Walleye Trading LLC holds 2,300 shares of BCYC stock, worth $20,148. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,300Holding current value
$20,148% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding BCYC
# of Institutions
117Shares Held
42MCall Options Held
111KPut Options Held
16.6K-
Baker Bros. Advisors LP New York, NY10.9MShares$95.4 Million0.77% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.45MShares$30.2 Million6.5% of portfolio
-
Armistice Capital, LLC New York, NY2.8MShares$24.5 Million0.34% of portfolio
-
Westfield Capital Management CO LP Boston, MA2.66MShares$23.3 Million0.12% of portfolio
-
Siren, L.L.C. New York, NY2.01MShares$17.6 Million0.72% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $260M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...